Medican Enterprises Inc. (MDCN) 0.0210 $MDCN Penny

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Medican Enterprises Inc. (MDCN) 0.0210 $MDCN

Penny Stocks Movers for Medican Enterprises, Advanced Medical Isotope, Radiant Creations Group, CIG Wireless, MRI Interventions, and NuGene
PR Newswire - Wed Mar 25, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Medican Enterprises (OTCMKTS:MDCN), Advanced Medical Isotope (OTCMKTS:ADMD), Radiant Creations Group (OTCBB:RCGP), CIG Wireless (OTCBB:CIGW), MRI Interventions (OTCBB:MRIC), and NuGene (OTCBB:NUGN).

Pot Stock Crash Redux: $23.3B Loss?
Matthew Finston - at Seeking Alpha - Sun Mar 08, 12:42AM CST


48 Marijuana Stocks - A Post-Mortem: Part I
Anthony Cataldo - at Seeking Alpha - Tue Mar 03, 1:27AM CST

GWPH: 91.13 (+2.73)

Marijuana Stocks: Seeking Liquidity
Matthew Finston - at Seeking Alpha - Mon Mar 02, 7:24AM CST


Medican Enterprises and JTB Real Estate extend closing date of Arizona property acquisition deal
M2 - Thu Feb 19, 6:31AM CST
Medican Enterprises Inc (OTCBB:MDCN.OB), a company seeking opportunities in the medical and recreational marijuana sector, announced on Wednesday that with JTB Real Estate LLLP (JTB), the companies have agreed to extend the closing date of the acquisition of 7,200 square foot retail and commercial property in Phoenix, Arizona.

Medican Enterprises and JTB Real Estate LLLP Agree to Extension of the Closing Date for the of Arizona Property Acquisition
Business Wire - Wed Feb 18, 11:58AM CST
Medican Enterprises Inc. (OTCBB:MDCN) (the "Company" or "Medican Enterprises", a company seeking promising pharmaceutical and other business opportunities in the emerging medical and recreational marijuana sector, announced today that the Company and JTB Real Estate LLLP ("JTB" have agreed to extend the closing date of the previously announced acquisition. The acquisition of the 7,200 square foot retail and commercial property in Phoenix, Arizona was detailed in the press release dated January 20, 2015. The building acquisition brings near-term revenue and cash flow potential. Both parties are aggressively working together to close on or before March 31, 2015.

Medican Forms Medican Nations to Partner with Indian Communities on Agriculture and Marijuana Businesses
Business Wire - Wed Feb 04, 7:00AM CST
Medican Enterprises Inc. (OTCBB:MDCN) today announced the formation of a new wholly owned subsidiary called Medican Nations, LLC (Medican Nations) and the appointment of Demitri Downing as Chief Executive Officer of Medican Nations.

Medican Enterprises Announces Extension to Closing of Acquisition Arizona Property
Business Wire - Fri Jan 30, 7:00AM CST
Medican Enterprises Inc. (OTCBB:MDCN), a company seeking promising pharmaceutical and other business opportunities in the emerging medical and recreational marijuana sector, announces that further to its press release of January 20, 2015 Medican has entered into a purchase agreement to acquire a retail and commercial property leased to a State Licensed Dispensary in Phoenix, Arizona.

Medican Enterprises Provides Shareholder Update
Business Wire - Wed Jan 28, 7:01AM CST
Medican Enterprises Inc. (OTCBB:MDCN), a company seeking promising pharmaceutical and other business opportunities in the emerging medical and recreational marijuana sector, today has provided shareholders with an update on its corporate accomplishments and business development plans in a shareholder letter from Chief Executive Officer Kenneth Williams. It reads:

Medican Enterprises executes purchase agreement for 7200 square feet retail and commercial property in Phoenix, Arizona
M2 - Wed Jan 21, 4:44AM CST
Medican Enterprises Inc (OTC:MDCN), a company seeking business opportunities in the medical and recreational marijuana sector, announced on Tuesday that it has entered into a purchase agreement to acquire a 7,200 square foot retail and commercial property in Phoenix, Arizona.

Medican Enterprises to Purchase 7200 sq ft Retail and Commercial Property in Phoenix
Business Wire - Tue Jan 20, 7:01AM CST
Medican Enterprises Inc. (OTCBB:MDCN), a company seeking promising pharmaceutical and other business opportunities in the emerging medical and recreational marijuana sector, announced that it has entered into a purchase agreement to acquire a 7,200 square foot retail and commercial property in Phoenix, Arizona.

12 Marijuana Stocks For Your Do Not 'Buy And Hold' List - Part VI
Anthony Cataldo - at Seeking Alpha - Fri Jan 16, 1:21PM CST

INSY: 58.13 (+1.08), GWPH: 91.13 (+2.73), FULL: 3.52 (-0.03)

Canada's Marijuana Market: The Good, Bad, And Ugly
Matthew Finston - at Seeking Alpha - Wed Dec 31, 8:55AM CST


American Cannabis Company, A Delaware Corporation, Joins The List Of At Least 46 Other Marijuana Stocks
Anthony Cataldo - at Seeking Alpha - Sun Dec 07, 5:36PM CST

GWPH: 91.13 (+2.73), FULL: 3.52 (-0.03)

Medican To Launch Real Estate Leasing And Marijuana Services Business Through Acquisition Of 67,000 Square Foot Industrial Property In Phoenix
Business Wire - Tue Dec 02, 7:02AM CST
Medican Enterprises Inc. (OTCBB:MDCN), a company seeking promising pharmaceutical and other business opportunities in the emerging medical and recreational marijuana sector, today announced that it has signed an agreement to acquire a 67,000 square foot facility in Phoenix, Arizona which the company plans to lease as a marijuana growing and warehouse facility to licensed growers.

Medican Enterprises Signs Binding Letter of Intent to Acquire Indoor Growing and Hydroponic Equipment Manufacturer Future Harvest Development
Business Wire - Tue Oct 21, 7:02AM CDT
Medican Enterprises Inc. (OTCBB:MDCN), a bio-pharmaceutical company in the emerging global marijuana industry, is pleased to announce that, in line with its mandate to acquire revenue generating assets, its wholly owned subsidiary Medican Systems has entered into a binding letter of intent to acquire Future Harvest Development Ltd., a leading Canadian manufacturing company in the home and garden, indoor growing, and hydroponic sectors.

Medican Enterprises names Drew Milburn as CEO of US subsidiary
M2 - Fri Oct 03, 5:34AM CDT
Medican Enterprises Inc (OTC:MDCN) on Thursday announced the appointment of Drew Milburn to the position of chief executive officer of Medican (US) Systems Inc (Medican US), the company's wholly owned subsidiary.

Medican Enterprises Appoints Drew Milburn as CEO of its U.S. Subsidiary
Business Wire - Thu Oct 02, 10:14AM CDT
Medican Enterprises, Inc. has appointed Drew Milburn to the position of Chief Executive Officer of Medican (US) Systems, Inc. (Medican US), a wholly owned subsidiary of Medican Enterprises, Inc. (OTCBB:MDCN).

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 13

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 14

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 14

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 15

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 14

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Telehealth Trends: A Comprehensive Yearly Insight

Updated Category News Views 346

FAIR Health's Telehealth Tracker: A Milestone Year FAIR Health has reached a significant milestone with its Monthly Telehealth Regional Tracker entering its sixth year. This tracker provides valuable insights into how telehealth usage has evolved, empowering stakeholders to understand trends in healthcare delivery. New Features and Data Insights The latest iteration of...

Continue Reading
Exploring Analog Devices: A $1000 Investment Journey

Updated Category News Views 139

The Growth of Analog Devices Inc (NASDAQ: ADI) Investors have increasingly turned their attention to Analog Devices Inc, a leader in the semiconductor industry. Over the last five years, Analog Devices has consistently outperformed the market, showcasing an annualized return of 16.0%. With a current market capitalization standing at an impressive $119.42 billion, the...

Continue Reading
Celebrating Excellence in Clinical Simulation: Meet the Nominees

Updated Category News Views 110

Highlighting Excellence in Clinical Simulation Awards A Representation of the Best in Simulation Healthcare Education in 2024 Education Management Solutions (EMS), a frontrunner in healthcare simulation and competency management platforms, has proudly announced its nominees for the 16th Annual Excellence in Clinical Simulation Awards. Each year, this noteworthy event...

Continue Reading
Significant Oil Price Drop Benefits Airlines and Cruise Lines

Updated Category News Views 195

Oil Prices Experience a Significant Drop Amid Easing Tensions Oil prices witnessed a noticeable decrease recently, plummeting over 5% during early trading in New York. This shift came as geopolitical tensions in the Middle East appeared to stabilize after an assurance from Israeli Prime Minister Benjamin Netanyahu that Iran’s oil facilities would not be targets in any...

Continue Reading
RxSight, Inc. Faces Legal Challenges: Investors Invited to Join Lawsuit

Updated Category News Views 136

RxSight, Inc. Investors Invited to Participate in Class Action Lawsuit Investors of RxSight, Inc. are becoming aware of significant opportunities to engage in a class action lawsuit. This legal action is being initiated by Bronstein, Gewirtz & Grossman, LLC, a law firm with a national reputation for advocating on behalf of investors. They are notifying shareholders that...

Continue Reading